Corrected Version: IL-12 p40 Monomer is Different from Other IL-12 Family Members to Selectively Inhibit IL-12Rβ1 Internalization and Suppress EAE
Journal of Clinical & Experimental Immunology · 13.07.2026 · 11 (03) · 01-38
DOI: 10.33140/jcei.11.03.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical & Experimental Immunology, online erschienen am 13.07.2026. Verfasst von Susanta Mondal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Sciences, Rush University Medical Center, Chicago, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, BLRD VA, NIA NIH HHS.
Abstract (Originalsprache)
Multiple sclerosis (MS) is the most common human demyelinating disease of the CNS. The IL-12 family of cytokines has four members which are IL-12 (p40:p35), IL-23 (p40:p19), the p40 monomer (p40), and the p40 homodimer (p402 ). Since all four members contain p40 in different forms, it is important to use specific monoclonal antibody (mAb) to characterize these molecules. Here, by using such mAb, we describe selective loss of p40 in serum of MS patients as compared to healthy controls. Similarly, we also observed decrease in p40 and increase in IL-12, IL-23 and p402 in serum of mice with experimental autoimmune encephalomyelitis (EAE), an animal model of MS, as compared to control mice. Interestingly, weekly supplementation of mouse and human recombinant p40 ameliorated clinical symptoms and disease progression of EAE. On the other hand, IL-12, IL-23 and p402 did not exhibit such inhibitory effect. In addition to EAE, p40 also suppressed collagen-induced arthritis in mice. Using IL-12Rβ1-/-, IL-12Rβ2-/- and IL-12Rβ1+/-/IL12Rβ2-/- mice, we observed that p40 required IL-12Rβ1, but not IL-12Rβ2, to suppress EAE. Interestingly, p40 arrested IL-12-, IL-23- or p402 -mediated internalization of IL-12Rβ1, but neither IL-12Rβ2 nor IL-23R, protected regulatory T cells, and suppressed Th1 and Th17 biasness. These studies identify p40 as a new anti-autoimmune cytokine with biological role different from IL-12, IL-23 and p402 in which it attenuates autoimmune signaling via suppression of IL12Rβ1 internalization, which may be beneficial in patients with MS and other autoimmune disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurological Sciences, Rush University Medical Center, Chicago, USA.
- Division of Research and Development, Jesse Brown Veterans Affairs Medical Center, Chicago, USA.
- Department of Neurology, Northwestern University, Chicago, USA.
ORCID-Profile: Kalipada Pahan
Förderung
- NINDS NIH HHS
- BLRD VA
- NIA NIH HHS
- NCCIH NIH HHS
Zitieren
APA
Mondal, S., Kundu, M., Jana, M., Rangasamy, S. B., Modi, K. K., Balabanov, R., & Pahan, K. (2026). Corrected Version: IL-12 p40 Monomer is Different from Other IL-12 Family Members to Selectively Inhibit IL-12Rβ1 Internalization and Suppress EAE. Journal of Clinical & Experimental Immunology, 11(03), 01-38. https://doi.org/10.33140/jcei.11.03.02
Vancouver
Mondal S, Kundu M, Jana M, Rangasamy SB, Modi KK, Balabanov R, et al. Corrected Version: IL-12 p40 Monomer is Different from Other IL-12 Family Members to Selectively Inhibit IL-12Rβ1 Internalization and Suppress EAE. Journal of Clinical & Experimental Immunology. 2026;11(03):01-38. doi:10.33140/jcei.11.03.02
BibTeX
@article{Mondal2026,
author = {Mondal, Susanta and Kundu, Madhuchhanda and Jana, Malabendu and Rangasamy, Suresh B and Modi, Khushbu K and Balabanov, Roumen and Pahan, Kalipada},
title = {Corrected Version: IL-12 p40 Monomer is Different from Other IL-12 Family Members to Selectively Inhibit IL-12Rβ1 Internalization and Suppress EAE},
journal = {Journal of Clinical & Experimental Immunology},
year = {2026},
volume = {11},
number = {03},
pages = {01--38},
doi = {10.33140/jcei.11.03.02}
}
EUVIMED